Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for ...
June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Apr. 24, 2024 — Study ...
MedPage Today on MSN3d
FDA Expands Guselkumab Approval to Crohn's DiseaseThe FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...
Crohn’s Disease is a chronic inflammatory bowel disease, and one-third of patients have no response to initial treatment with tumor necrosis factor (TNF) antagonists. Some patients have a very ...
Passing mucus in the stool is less common in people with Crohn's disease. It can sometimes mean that you're ... Some people who have had ostomy surgery (either ileostomy or colostomy) may pass mucus ...
Bleeding varices (internal bleeding). UChicago Medicine. Liver failure. UCSF Department of Surgery. End-stage liver disease (ESLD). American Cancer Society. Signs and symptoms of stomach cancer. MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback